Explore PDS Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PDSB. PDS Biotechnology – Top-Line Data From Its Lead Candidate Points To ...

OptiNose OPTN stock skyrocketed after the company announced that it was set to be acquired by Paratek Pharmaceuticals, a private biotech. This deal will add OPTN’s approved product, Xhance ...

During this period, the company's stock will continue trading on the Nasdaq Capital Market under the ticker symbol "ONCY." To regain compliance, the closing bid price of Oncolytics Biotech's ...

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the ...

Fidelity Select Biotechnology Portfolio earns an Average ... Analyzing additional factors, this strategy tilts consistently toward stocks with lower quality or the shares of companies with more ...

MAIA Biotechnology's Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In ...

In this article, we are going to take a look at where MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...

The improved sales of Nerlynx have been the primary reason for the stock’s increase in the past six months. Puma Biotechnology in-licensed the global development and commercialization rights to ...